🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the efficacy of perampanel...
Status
Completed
Location
Eisai Site #9
Start Date
2022-10-19
Trial ID
NCT05533814
Treatments Being Tested
The purpose of the study is to determine the efficacy and safety of Perampa...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00592774
Treatments Being Tested
The purpose of this study is to explore the maximum tolerated dose of E2007...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00849212
Treatments Being Tested
This was a 22-week, prospective, randomized, double-blind, placebo-controll...
Status
Completed
Location
Investigational Site
Start Date
2005-01
Trial ID
NCT00154063
The purpose of the study is to evaluate the safety and tolerability of pera...
Status
Completed
Location
Eisai trial site 5
Start Date
2018-11-27
Trial ID
NCT03754582
Treatments Being Tested
This is a randomized, double-blind, two treatment, two group, parallel grou...
Status
Completed
Location
Clinical Trials Incorporated
Start Date
2005-09
Trial ID
NCT00165789
Treatments Being Tested
The main objective of this EAP is to ensure that participants participating...
Status
No Longer Available
Location
Cliniques Universitaires Saint-Luc
Start Date
TBD
Trial ID
NCT02307578
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy and tolerabil...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2008-04-30
Trial ID
NCT00699972
Treatments Being Tested
The purpose of this study is to confirm the efficacy and safety of perampan...
Status
Completed
Location
Facility #1
Start Date
2012-05-15
Trial ID
NCT01618695
Treatments Being Tested
The Extended Access Program (EAP) is a managed access programme for Perampa...
Status
No Longer Available
Location
Fundacion Cerebro Y Mente
Start Date
TBD
Trial ID
NCT01871233
Treatments Being Tested